Literature DB >> 27246341

Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells.

Fiona M Frame1, Davide Pellacani2, Anne T Collins2, Norman J Maitland3.   

Abstract

In order to fully explore the biology of a complex solid tumor such as prostate cancer, it is desirable to work with patient tissue. Only by working with cells from a tissue can we take into account patient variability and tumor heterogeneity. Cell lines have long been regarded as the workhorse of cancer research and it could be argued that they are of most use when considered within a panel of cell lines, thus taking into account specified mutations and variations in phenotype between different cell lines. However, often very different results are obtained when comparing cell lines to primary cells cultured from tissue. It stands to reason that cells cultured from patient tissue represents a close-to-patient model that should and does produce clinically relevant data. This chapter aims to illustrate the methods of processing, storing and culturing cells from prostate tissue, with a description of potential uses.

Entities:  

Keywords:  Benign prostatic hyperplasia; Cancer; Primary epithelial cells; Prostate; Tissue

Mesh:

Year:  2016        PMID: 27246341     DOI: 10.1007/978-1-4939-3724-0_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.

Authors:  Leanne K Archer; Fiona M Frame; Hannah F Walker; Alastair P Droop; Georgina L K McDonald; Samuel Kucko; Daniel M Berney; Vincent M Mann; Matthew S Simms; Norman J Maitland
Journal:  FEBS Open Bio       Date:  2022-05-06       Impact factor: 2.792

2.  Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.

Authors:  Amanda R Noble; Norman J Maitland; Daniel M Berney; Martin G Rumsby
Journal:  Br J Cancer       Date:  2017-11-14       Impact factor: 7.640

3.  Phenotype-independent DNA methylation changes in prostate cancer.

Authors:  Davide Pellacani; Alastair P Droop; Fiona M Frame; Matthew S Simms; Vincent M Mann; Anne T Collins; Connie J Eaves; Norman J Maitland
Journal:  Br J Cancer       Date:  2018-10-15       Impact factor: 7.640

4.  Targeting Semaphorin 3C in Prostate Cancer With Small Molecules.

Authors:  Chung C W Lee; Ravi Shashi Nayana Munuganti; James W Peacock; Kush Dalal; Ivy Z F Jiao; Ashley Shepherd; Liangliang Liu; Kevin J Tam; Colin G Sedgwick; Satyam Bhasin; Kevin C K Lee; Luke Gooding; Benjamin Vanderkruk; Tabitha Tombe; Yifan Gong; Martin E Gleave; Artem Cherkasov; Christopher J Ong
Journal:  J Endocr Soc       Date:  2018-10-11

5.  Effects on prostate cancer cells of targeting RNA polymerase III.

Authors:  John L Petrie; Caroline Swan; Richard M Ingram; Fiona M Frame; Anne T Collins; Hélène Dumay-Odelot; Martin Teichmann; Norman J Maitland; Robert J White
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

6.  The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.

Authors:  Robert I Seed; Alberto J Taurozzi; Daniel J Wilcock; Giovanna Nappo; Holger H H Erb; Martin L Read; Mark Gurney; Leanne K Archer; Saburo Ito; Martin G Rumsby; John L Petrie; Aled Clayton; Norman J Maitland; Anne T Collins
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

Review 7.  Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance.

Authors:  Fiona M Frame; Norman J Maitland
Journal:  Int J Mol Sci       Date:  2019-05-17       Impact factor: 5.923

8.  Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.

Authors:  John R Packer; Adam M Hirst; Alastair P Droop; Rachel Adamson; Matthew S Simms; Vincent M Mann; Fiona M Frame; Deborah O'Connell; Norman J Maitland
Journal:  FEBS Lett       Date:  2019-09-17       Impact factor: 4.124

9.  Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target.

Authors:  Luca Quattrini; Maria Sadiq; Giovanni Petrarolo; Norman J Maitland; Fiona M Frame; Klaus Pors; Concettina La Motta
Journal:  Biomedicines       Date:  2020-12-04

10.  Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.

Authors:  Ali I M Ibrahim; Elisabet Batlle; Smarakan Sneha; Rafael Jiménez; Raquel Pequerul; Xavier Parés; Till Rüngeler; Vibhu Jha; Tiziano Tuccinardi; Maria Sadiq; Fiona Frame; Norman J Maitland; Jaume Farrés; Klaus Pors
Journal:  J Med Chem       Date:  2022-02-25       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.